Cytosorbents Corporation

NasdaqCM:CTSO Stok Raporu

Piyasa değeri: US$54.4m

Cytosorbents Yönetim

Yönetim kriter kontrolleri 2/4

Cytosorbents CEO'su Phil Chan, Jan2009 tarihinde atandı, in görev süresi 15.83 yıldır. in toplam yıllık tazminatı $ 1.33M olup, şirket hissesi ve opsiyonları dahil olmak üzere 36.2% maaş ve 63.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 1.36% ine doğrudan sahiptir ve bu hisseler $ 739.37K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 6 yıl ve 10.2 yıldır.

Anahtar bilgiler

Phil Chan

İcra Kurulu Başkanı

US$1.3m

Toplam tazminat

CEO maaş yüzdesi36.2%
CEO görev süresi15.8yrs
CEO sahipliği1.4%
Yönetim ortalama görev süresi6yrs
Yönetim Kurulu ortalama görev süresi10.2yrs

Son yönetim güncellemeleri

Recent updates

The Market Lifts Cytosorbents Corporation (NASDAQ:CTSO) Shares 43% But It Can Do More

Oct 01
The Market Lifts Cytosorbents Corporation (NASDAQ:CTSO) Shares 43% But It Can Do More

Investors Continue Waiting On Sidelines For Cytosorbents Corporation (NASDAQ:CTSO)

Jul 04
Investors Continue Waiting On Sidelines For Cytosorbents Corporation (NASDAQ:CTSO)

Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

Mar 16
Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

Take Care Before Jumping Onto Cytosorbents Corporation (NASDAQ:CTSO) Even Though It's 28% Cheaper

Jan 06
Take Care Before Jumping Onto Cytosorbents Corporation (NASDAQ:CTSO) Even Though It's 28% Cheaper

Is Cytosorbents (NASDAQ:CTSO) Using Too Much Debt?

Nov 10
Is Cytosorbents (NASDAQ:CTSO) Using Too Much Debt?

Shareholders Should Be Pleased With Cytosorbents Corporation's (NASDAQ:CTSO) Price

Jul 13
Shareholders Should Be Pleased With Cytosorbents Corporation's (NASDAQ:CTSO) Price

Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

May 16
Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

Mar 08
We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

CytoSorbents secures $4.3M contract by U.S. Department of Defense

Oct 06

CytoSorbents stock rises on US DoD contract to develop device for universal plasma

Sep 09

We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

Sep 02
We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

CytoSorbents gets reimbursement for CytoSorb in Turkey

Aug 23

CytoSorbents stock rises 10% as Israel approves coverage for CytoSorb system

Aug 17

Cytosorbents GAAP EPS of -$0.25 misses by $0.13, revenue of $8.5M misses by $1.06M

Aug 02

CEO Tazminat Analizi

Phil Chan'un ücretlendirmesi Cytosorbents'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$26m

Mar 31 2024n/an/a

-US$28m

Dec 31 2023US$1mUS$483k

-US$29m

Sep 30 2023n/an/a

-US$23m

Jun 30 2023n/an/a

-US$26m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$1mUS$483k

-US$33m

Sep 30 2022n/an/a

-US$41m

Jun 30 2022n/an/a

-US$36m

Mar 31 2022n/an/a

-US$29m

Dec 31 2021US$2mUS$483k

-US$25m

Sep 30 2021n/an/a

-US$16m

Jun 30 2021n/an/a

-US$10m

Mar 31 2021n/an/a

-US$9m

Dec 31 2020US$1mUS$456k

-US$8m

Sep 30 2020n/an/a

-US$11m

Jun 30 2020n/an/a

-US$17m

Mar 31 2020n/an/a

-US$18m

Dec 31 2019US$1mUS$438k

-US$19m

Sep 30 2019n/an/a

-US$21m

Jun 30 2019n/an/a

-US$17m

Mar 31 2019n/an/a

-US$19m

Dec 31 2018US$1mUS$400k

-US$17m

Sep 30 2018n/an/a

-US$15m

Jun 30 2018n/an/a

-US$14m

Mar 31 2018n/an/a

-US$10m

Dec 31 2017US$828kUS$378k

-US$9m

Tazminat ve Piyasa: Phil 'nin toplam tazminatı ($USD 1.33M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 653.78K ).

Tazminat ve Kazançlar: Phil şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Phil Chan (54 yo)

15.8yrs

Görev süresi

US$1,333,402

Tazminat

Dr. Phillip P. Chan, M.D., Ph D., is known as Phil has been the Chief Executive Officer at Cytosorbents Corporation since January 2009 and served as its President until May 2020. Dr. Chan serves as a Partn...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Phillip Chan
CEO & Director15.8yrsUS$1.33m1.36%
$ 739.4k
Vincent Capponi
President & COO19.3yrsUS$1.11m0.52%
$ 281.1k
Kathleen Bloch
Chief Financial Officer1.3yrsUS$816.08k0.54%
$ 294.9k
Efthymios Deliargyris
Chief Medical Officer4.5yrsUS$1.06m0.17%
$ 94.0k
Terri Powers
Vice President of Investor Relations & Corporate Communications3.4yrsVeri yokVeri yok
Christian Steiner
Executive Vice President of Sales & Marketing12.4yrsVeri yokVeri yok
Christopher Cramer
Senior Vice President of Business Development1.8yrsVeri yokVeri yok
Jodi Hoover
Executiveno dataVeri yokVeri yok
Robert Bartlett
Co-Chairman of Cardiac Surgery Advisory Board & Consultant7.4yrsUS$97.32kVeri yok

6.0yrs

Ortalama Görev Süresi

66yo

Ortalama Yaş

Deneyimli Yönetim: CTSO 'un yönetim ekibi deneyimli ve deneyimlidir ( 6 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Phillip Chan
CEO & Director16.3yrsUS$1.33m1.36%
$ 739.4k
Robert Bartlett
Co-Chairman of Cardiac Surgery Advisory Board & Consultant10.2yrsUS$97.32kVeri yok
Claudio Ronco
Member of Critical Care Advisory Boardno dataVeri yokVeri yok
Alan Sobel
Independent Director10yrsUS$118.47k0.063%
$ 34.6k
Edward Jones
Independent Director17.6yrsUS$101.93k0.036%
$ 19.5k
Joseph Parrillo
Member of Critical Care Advisory Boardno dataVeri yokVeri yok
Ronald Maier
Chairman of the Trauma Advisory Board11.6yrsVeri yokVeri yok
Mitchell Cohen
Member of Trauma Advisory Boardno dataVeri yokVeri yok
Ernest Moore
Member of Trauma Advisory Board11.6yrsVeri yokVeri yok
Joseph Zwischenberger
Chairman of Cardiac Surgery Advisory Board10.2yrsVeri yokVeri yok
Jonathan Haft
Member of Cardiac Surgery Advisory Board10.2yrsVeri yokVeri yok
Michael Bator
Independent Chairman of the Board9.3yrsUS$161.70k0.10%
$ 56.1k

10.2yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CTSO 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 10.2 yıldır).